A Look Back at Jan 6 + Free My News Bias for One MonthCheck it out
|Login
Ground News Logo
Jan 17, 2022SUBSCRIBE NOW

US approval for Moderna teen vaccines delayed

WASHINGTON - US biotech firm Moderna said Sunday that American officials have delayed approving its Covid-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
3 months ago|Washington, United States

BIAS COVERAGE DISTRIBUTION

57 of these news sources are bias rated
30 are CENTER
L 25%
C 48%
R 27%
Raw Story
Global News
NDTV
USA Today
abc News
+9
Reuters
CBS Local
CNBC
Associated Press News
+27
Washington Times
Russia Today
MY Northwest
News
+9
The Western Journal
InfoWars
ALL ARTICLES
Yahoo News
Yahoo News

Moderna: FDA delaying decision on its shot for adolescents

U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday. The U.S. Food and Drug Administration told the company Friday evening that its review could last until January, Moderna said. The company also said it will delay filing a request for emergency-use authorization of a lower dose of the vaccine for 6- to 11-year-olds.

3 months ago|Los Angeles, United States
Reuters
ReutersC

Moderna says FDA needs more time to complete review of its COVID-19 shot for adolescents

- Moderna Inc said on Sunday it has been told that the U.S. Food and Drug Administration will require additional time to complete its assessment of the company's COVID-19 vaccine for use in adolescents aged 12 to 17 years. The FDA informed Moderna that the review may not be completed before January 2022, the company said in a statement, dealing a potential setback to the timing of an

3 months ago|United Kingdom
Global News
Global NewsL

Moderna says FDA delaying decision on its adolescent COVID-19 vaccine shot - National

The U.S. Food and Drug Administration told the company Friday evening that its review could last until January, Moderna said.

3 months ago|Toronto, Canada
CBS Local
CBS LocalC

Moderna Says FDA Delaying Decision On Its COVID-19 Vaccine For Kids 12-17

CAMBRIDGE, Mass. (AP) — U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation.Moderna said Sunday that the U.S. Food and Drug Administration told the company Friday evening that its review could last until January.The company also says it will delay filing a request for emergency-use authorization of a lower dose of the vaccine for 6- to 11-year-olds…

3 months ago|United States
NDTV
NDTVL

US Delays Approval For Moderna Covid Vaccine In Teenagers

US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.

3 months ago|New Delhi, India
USA Today
USA TodayL

FDA delays decision on Moderna vaccine for kids 12 and up: Live COVID updates

Regulatory approval of Moderna’s request for its vaccine for kids 12 to 17 has been delayed until at least January, Moderna says. Latest COVID news.

3 months ago|United States
Washington Times
Washington TimesR

FDA delays decision on Moderna vaccine for adolescents

CAMBRIDGE, Mass. — U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.The U.S. Food and Drug Administration told the company Friday evening that its review could last until January, Moderna said. ...

3 months ago|Washington, United States
abc News
abc NewsL

Moderna: FDA delaying decision on its shot for adolescents

U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation

3 months ago|United States
CNBC
CNBCC

Moderna says FDA needs more time to review its Covid vaccine for teens

Moderna said the FDA needs more time to complete its review of its Covid-19 vaccine for 12-to-17-year-olds before granting emergency use authorization.

3 months ago|United States
Associated Press News
Associated Press NewsC

Moderna: FDA delaying decision on its shot for adolescents

CAMBRIDGE, Mass. (AP) — U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.

3 months ago|United States
COVERAGE DETAILS

BIAS COVERAGE DISTRIBUTION

57 of these news sources are bias rated
30 are CENTER
L 25%
C 48%
R 27%
Raw Story
Global News
NDTV
USA Today
abc News
New York Times
CBS News
The Washington Post
Business Insider
NBC News
Koco News5
Boston.com
+2
Reuters
CBS Local
CNBC
Associated Press News
IBTimes
The Hill
Channel News Asia
The Business Journals
npr
Bangkok Post
UPI
+20
Washington Times
Russia Today
MY Northwest
News
Las Vegas Review-Journal
Boston Herald
justthenews.com
KSL
Fox Business
Le Figaro
Investor's Business Daily
+2
The Western Journal
InfoWars
Total News Sources81Leaning Left13 sourcesLeaning Right14 sourcesCenter30 sourcesLast Updated3 months ago
0
TOPICS
SIMILAR STORIES